Researchers report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
from http://besthealthnews.com/2019/10/why-targeted-immuno-oncology-drugs-sometimes-fail/?utm_source=rss&utm_medium=rss&utm_campaign=why-targeted-immuno-oncology-drugs-sometimes-fail
from
https://healthnews010.tumblr.com/post/188555020168
from https://johnher1.blogspot.com/2019/10/why-targeted-immuno-oncology-drugs.html
from
https://johnher10.tumblr.com/post/188555172062
No comments:
Post a Comment